Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sialic acid residues, primarily N-acetylneuraminic acid (Neu5Ac), are terminal sugar molecules found on the glycan chains of glycoproteins and glycolipids on the surface of human respiratory epithelial cells (Varki A, 2008). These residues serve as critical attachment points for various pathogens, most notably the influenza virus, which utilizes its hemagglutinin protein to bind to specific sialic acid linkages. Specifically, alpha-2,6 linkages are predominant in the human upper respiratory tract, while alpha-2,3 linkages are more common in the lower respiratory tract and avian species (Shinya K, et al., 2006; Nicholls JM, et al., 2007). Beyond viral entry, sialic acids play essential roles in cell-cell recognition, immune system modulation, and maintaining the structural integrity of the mucus layer. In pharmacology, sialic acids are the substrate for the viral enzyme neuraminidase; drugs like oseltamivir inhibit this enzyme to prevent the release of new viral particles from infected cells. Additionally, therapeutic strategies like DAS181 (Fludase) involve the direct enzymatic removal of these residues from the host cell surface to block viral infection (Moss RB, et al., 2011).
Neuraminidase inhibition (prevents viral release by blocking the cleavage of sialic acid) and Sialidase activity (enzymatic removal of sialic acid residues to prevent viral entry).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-acetylneuraminic acid (Sialic acid) (Neu5Ac).